Total Payments
$414.45
2024 Payments
$20.00
Companies
6
Transactions
22
Medicare Patients
5,199
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$394.45 (95.2%)
Other$20.00 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $394.45 | 21 | 95.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $193.63 | 13 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $83.89 | 1 | $0 (2018) |
| Allergan Inc. | $55.68 | 3 | $0 (2018) |
| Synergy Pharmaceuticals Inc | $44.12 | 3 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.63 | 1 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.50 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.00 | 1 | ABBVIE INC. ($20.00) |
| 2019 | $51.49 | 3 | AbbVie, Inc. ($51.49) |
| 2018 | $247.53 | 11 | Janssen Scientific Affairs, LLC ($83.89) |
| 2017 | $95.43 | 7 | AbbVie, Inc. ($79.34) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/07/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $16.80 | General |
| 06/07/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Immunology | ||||||
| 03/13/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Immunology | ||||||
| 07/24/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Gastroenterology | ||||||
| 07/16/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/28/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Lower GI | ||||||
| 06/28/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Immunology | ||||||
| 04/19/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Gastroenterology | ||||||
| 03/27/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/22/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Endocrinology | ||||||
| 03/14/2018 | Janssen Scientific Affairs, LLC | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $83.89 | General |
| Category: Immunology | ||||||
| 03/13/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Virology | ||||||
| 03/01/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Gastroenterology | ||||||
| 01/17/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Endocrinology | ||||||
| 07/17/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Endocrinology | ||||||
| 05/16/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Endocrinology | ||||||
| 04/12/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Immunology | ||||||
| 02/13/2017 | AbbVie, Inc. | Technivie (Drug), Viekira | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Virology | ||||||
| 01/06/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,222 | 18,734 | $974,480 | $389,871 |
| 2022 | 22 | 1,563 | 13,751 | $856,205 | $322,340 |
| 2021 | 23 | 1,328 | 7,715 | $525,580 | $195,838 |
| 2020 | 17 | 1,086 | 8,095 | $458,595 | $187,898 |
Total Patients
5,199
Total Services
48,295
Medicare Billing
$1.1M
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 36 | 15,300 | $382,500 | $263,580 | 68.9% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 23 | 2,070 | $310,500 | $55,253 | 17.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 57 | 57 | $48,450 | $10,534 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 111 | $20,705 | $10,140 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 153 | $20,075 | $9,553 | 47.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $17,215 | $7,982 | 46.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 37 | 37 | $24,050 | $6,575 | 27.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 44 | 44 | $33,000 | $5,258 | 15.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 167 | 167 | $5,845 | $3,761 | 64.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 29 | 37 | $16,465 | $3,627 | 22.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 62 | 62 | $38,440 | $3,453 | 9.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 45 | 63 | $12,600 | $2,919 | 23.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $9,100 | $2,491 | 27.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 12 | $8,400 | $1,057 | 12.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 26 | $2,210 | $967.20 | 43.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 88 | 110 | $1,100 | $898.80 | 81.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 28 | 39 | $4,875 | $853.32 | 17.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 168 | 168 | $12,600 | $619.80 | 4.9% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 12 | 12 | $1,800 | $260.92 | 14.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 71 | 182 | $4,550 | $88.45 | 1.9% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 26 | 10,800 | $270,000 | $188,065 | 69.7% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 16 | 1,250 | $187,500 | $35,441 | 18.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 96 | 96 | $81,600 | $18,944 | 23.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 66 | 67 | $43,550 | $11,899 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 177 | $23,010 | $11,171 | 48.5% |
About Dr. Richard Clift, M.D
Dr. Richard Clift, M.D is a Gastroenterology healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215969316.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Clift, M.D has received a total of $414.45 in payments from pharmaceutical and medical device companies, with $20.00 received in 2024. These payments were reported across 22 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($394.45).
As a Medicare-enrolled provider, Clift has provided services to 5,199 Medicare beneficiaries, totaling 48,295 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Albany, NY
- Active Since 07/07/2006
- Last Updated 07/18/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1215969316
Products in Payments
- STELARA (Biological) $83.89
- Humira (Biological) $76.33
- Creon (Drug) $46.60
- Trulance (Drug) $44.12
- VIBERZI (Drug) $35.73
- UCERIS (Drug) $22.63
- Mavyret (Drug) $20.42
- CREON (Drug) $20.00
- LINZESS (Drug) $19.95
- Amitiza (Drug) $14.50
- Technivie (Drug) $13.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Albany
Bora Gumustop, M.d, M.D
Gastroenterology — Payments: $106,464
Gastroenterology $106,464
Dr. Robert Gianotti, Md, MD
Gastroenterology — Payments: $57,850
Gastroenterology $57,850
Mandeep Bhamra, M.d, M.D
Gastroenterology — Payments: $44,830
Gastroenterology $44,830
Dr. Jeffrey Gerson, Md, MD
Gastroenterology — Payments: $32,008
Gastroenterology $32,008
Joseph Polito, M.d, M.D
Gastroenterology — Payments: $8,726
Gastroenterology $8,726
Dr. Seth Richter, M.d, M.D
Gastroenterology — Payments: $7,843
Gastroenterology $7,843